Korian continues its growth with resilient 2020 results and enters the high end UK care home market

Strong commitment and collective mobilisation to affront the pandemic
 Full Covid processes in place: hospital level hygiene standards audited by Bureau Veritas, adapted and
secured supply chain, 100,000 tests per week
 76% of residents1 and 43% of staff2 vaccinated
Korian delivering on its ESG roadmap taken in 2020, with tangible results
 Strong progression of net client satisfaction score3 by 400 bps and a gross satisfaction score of 94%
 Doubling of the number of staff engaged in qualifying training programs (from 4% to 8% of staff)
 Launch of low-carbon action plan in line with -40% roadmap (between 2018 and 2030)
Revenue up 7.2% (€ 3 874m) fuelled by resilient organic growth and active buy and build strategy
 2% organic growth supported by the geographical and activity mix
 New platforms in Spain and Netherlands bringing 20% of reported growth
 Additional healthcare capacities (post-acute, outpatient, mental health) represent 40% of reported growth
 Home care services confirm growth potential (+25% in 2020)
EBITDA Margin above guidance at 13.6% excluding one-off costs (12.9% with Covid-19 one-off costs)
Network of 1,000 facilities, 6,000 additional beds (+32% vs. 2019), of which 1,500 greenfield beds and
15 clinics with new outpatient places
Acceleration of diversification strategy
 2/3 of investments in high demand healthcare segment; including leading positions in mental health and
specialised post-acute care in France and digital innovation for e-care pathways
 Geographical expansion with exclusive negotiations to acquire high end platform in the UK in 2021
Strengthened balance sheet: financial leverage of 3.0x, real estate LTV of 55% on value of € 2.7bn
Proposed dividend of €0.30 per share
Guidance confirmed for 2022: >€4.5 billion revenue with 15.5% of EBITDA margin

Adapted to a long term Covid-19 environment and vaccination programme well advanced
Korian has been constantly mobilised throughout 2020 to protect its staff and residents from the Covid-19 virus
pandemic.
From March 2020, the Group has taken numerous initiatives to be able to operate on the long run in the Covid-
19 environment, such as:
- Deploying hospital level hygiene standards across the Group, audited by Bureau Veritas (98%
outstanding or very good level of compliance)
- adapted therapeutical protocols, in clinics as well as in nursing homes
- access to dedicated teleconsultation platforms (operated by Omedys in France)
- on-site testing capabilities for teams and external visitors
- permanent rolling stocks of PPE covering 2 months’ utilisation
- connexion tools to maintain links between patients and residents with families.